Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
Cancer Medicine|February 26, 2015
BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinomaLauren E Henke, John D Pfeifer, Changquing Ma, et al.International Journal of Radiation Oncology, Biology, Physics|August 3, 2014
Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastasesAdam A Garsa, Shahed N Badiyan, Todd DeWees, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2019
Eliminating Postoperative Radiation to the Pathologically Node-Negative Neck: Long-Term Results of a Prospective Phase II StudyJessika A Contreras, Christopher Spencer, Todd DeWees, et al.Journal of Applied Clinical Medical Physics|May 22, 2019
Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapiesChenbin Liu, Ronik S Bhangoo, Terence T Sio, et al.Cancer|September 8, 2017
Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsilRe-I Chin, Yuan James Rao, Michael Y Hwang, et al.Medical Physics|September 10, 2019
Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC)Chenbin Liu, Nathan Y Yu, Jie Shan, et al.International Journal of Radiation Oncology, Biology, Physics|July 29, 2026
Can Engagement aid in design and accrual on Clinical Trials? Observations from COMPPARE - A Prospective Comparison of Outcomes with Proton and Photon Radiation in Prostate CancerNancy P Mendenhall, Curtis M Bryant, Aaron J Katz, et al.International Journal of Radiation Oncology, Biology, Physics|September 27, 2014
Radiation therapy dose escalation for glioblastoma multiforme in the era of temozolomideShahed N Badiyan, Stephanie Markovina, Joseph R Simpson, et al.British Journal of Cancer|November 8, 2017
Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancerStephanie Markovina, Songyan Wang, Lauren E Henke, et al.Neurosurgery|December 10, 2015
Radiation Therapy for Residual or Recurrent Atypical Meningioma: The Effects of Modality, Timing, and Tumor Pathology on Long-Term OutcomesSam Q Sun, Chunyu Cai, Rory K J Murphy, et al.Pageof 7